Centiva Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,900
| Closed | -$45.3K | – | 2329 |
|
|
2024
Q4 | $45.3K | Sell |
14,900
-67,697
| -82% | -$295K | ﹤0.01% | 1548 |
|
|
2024
Q3 | $429K | Sell |
82,597
-58,662
| -42% | -$292K | 0.02% | 1356 |
|
|
2024
Q2 | $363K | Buy |
141,259
+126,259
| +842% | +$431K | 0.02% | 1359 |
|
|
2024
Q1 | $73.8K | Sell |
15,000
-10,885
| -42% | -$64.4K | ﹤0.01% | 1632 |
|
|
2023
Q4 | $228K | Sell |
25,885
-288,776
| -92% | -$2.37M | 0.01% | 1353 |
|
|
2023
Q3 | $3.61M | Buy |
314,661
+274,661
| +687% | +$5.28M | 0.18% | 225 |
|
|
2023
Q2 | $1.01M | Buy |
40,000
+13,800
| +53% | +$430K | 0.05% | 565 |
|
|
2023
Q1 | $844K | Buy |
+26,200
| New | +$817K | 0.05% | 659 |
|
